Does a history of adverse pregnancy outcomes affect late midlife blood pressure and subclinical vascular measures in parous women?
A history of preterm birth is associated with significantly higher systolic and diastolic blood pressure in late midlife, highlighting the importance of pregnancy history in cardiovascular risk assessment.
Background Adverse pregnancy outcomes, such as preterm birth ( PTB ), have been associated with elevated risk of maternal cardiovascular disease, but their effect on late midlife blood pressure (BP) and subclinical vascular measures remains understudied. Methods and Results We conducted a cross‐sectional analysis with 1220 multiethnic parous women enrolled in SWAN (Study of Women's Health Across the Nation) to evaluate the impact of self‐reported history of adverse pregnancy outcomes ( PTB , small‐for‐gestational‐age, stillbirth), on maternal BP , mean arterial pressure, and subclinical vascular measures (carotid intima‐media thickness, plaque, and pulse wave velocity) in late midlife. We also examined whether these associations were modified by race/ethnicity. Associations were tested in linear and logistic regression models adjusting for sociodemographics, reproductive factors, cardiovascular risk factors, and medications. Women were on average aged 60 years and 255 women reported a history of an adverse pregnancy outcome. In fully adjusted models, history of PTB was associated with higher BP (systolic: β=6.40; SE, 1.62 P <0.0001 and diastolic: β=3.18; SE , 0.98 P =0.001) and mean arterial pressure (β=4.55; SE 1.13 P <0.0001). PTB was associated with lower intima‐media thickness, but not after excluding women with prevalent hypertension. There were no significant associations with other subclinical vascular measures. Conclusions Findings suggest that history of PTB is associated with higher BP and mean arterial pressure in late midlife. Adverse pregnancy outcomes were not significantly related to subclinical cardiovascular disease when excluding women with prevalent hypertension. Future studies across the menopause transition may be important to assess the impact of adverse pregnancy outcomes on midlife progression of BP .
Cortés et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: